Skip to main content
PMC home page
Breast Cancer Research : BCR logoLink to Breast Cancer Research : BCR
. 2024 Mar 26;26:53. doi: 10.1186/s13058-024-01814-9

Correction: The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth

Jing Qian 1,8, Yanxia Ma 1,7, William M Tahaney 1,2,6, Cassandra L Moyer 1, Amanda Lanier 1, Jamal Hill 1, Darian Coleman 1, Negar Koupaei 1,4, Susan G Hilsenbeck 3, Michelle I Savage 1, Brent D G Page 5, Abhijit Mazumdar 1, Powel H Brown 1,2,✉
PMCID: PMC10967199  PMID: 38532428

Qian et al. Breast Cancer Research (2024) 26:23

10.1186/s13058-024-01778-w

The original article has incomplete funding information with regard to author Negar Koupaei. The complete funding note is as follows:

Funding

This work was funded by a Susan G Komen Promise Grant (KG081694 P.H.B.), a Komen SAB Grant (9SAB12-00006, P.H.B.), and a CCSG Grant (P30 CA016672, P.H.B.). This work was also supported by the John Charles Cain Endowment (P.H.B.). Negar Koupaei (NK) was supported by the 1R25CA240137-01A1 UPWARDS Training Program and by the CPRIT Research Training Award CPRIT Training Program (RP210028).

The original article [1] has been corrected.

Footnotes

The online version of the original article can be found at 10.1186/s13058-024-01778-w.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Qian J, Ma Y, Tahaney WM, et al. The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth. Breast Cancer Res. 2024;26:23. doi: 10.1186/s13058-024-01778-w. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Breast Cancer Research : BCR are provided here courtesy of BMC

RESOURCES